BMP9通过改善淋巴引流和触发DECR1介导的线粒体生物能量学保护心肌梗死
该研究探讨骨形态发生蛋白9(BMP9)在心肌梗死(MI)中的作用。发现MI患者和小鼠循环及心脏BMP9水平显著升高且与心功能负相关;BMP9缺失加重左室功能障碍、梗死面积和纤维化,而补充BMP9可减轻这些不良效应。机制上BMP9改善淋巴引流减少心脏水肿,并上调DECR1促进线粒体生物能量学,从而保护MI。
要点
- MI后BMP9代偿性升高且与心功能负相关
- BMP9缺失加重MI损伤,补充BMP9可减轻
- BMP9通过淋巴引流和DECR1线粒体途径保护心脏
核心结论
- BMP9通过调控肝脏、淋巴和心脏间的多器官交互作用保护心肌梗死。
研究设计与样本
- 检测MI患者和小鼠心脏组织及血浆BMP9表达谱,并在小鼠中评估BMP9缺失及补充(AAV介导BMP9表达或重组人BMP9蛋白)的影响。
主要发现
- MI患者和小鼠循环及心脏BMP9水平显著升高,且与心脏功能负相关。
- BMP9缺失加重小鼠MI后左室功能障碍、梗死面积和心脏纤维化,补充BMP9则显著减轻这些不良效应。
- BMP9改善淋巴引流功能,减少心脏水肿。
- BMP9上调线粒体DECR1(β-氧化限速酶)表达,促进心脏线粒体生物能量学并减轻MI诱导的心肌细胞损伤。
- DECR1缺失加重MI诱导的心脏损伤,且DECR1缺失消除BMP9对MI的保护作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: BMP9 (bone morphogenetic protein 9) is a member of the TGF-β (transforming growth factor β) family of cytokines with pleiotropic effects on glucose metabolism, fibrosis, and lymphatic development. However, the role of BMP9 in myocardial infarction (MI) remains elusive. METHODS: The expressional profiles of BMP9 in cardiac tissues and plasma samples of subjects with MI were determined by immunoassay or immunoblot. The role of BMP9 in MI was determined by evaluating the impact of BMP9 deficiency and replenishment with adeno-associated virus-mediated BMP9 expression or recombinant human BMP9 protein in mice. RESULTS: We show that circulating BMP9 and its cardiac levels are markedly increased in humans and mice with MI and are negatively associated with cardiac function. It is important to note that BMP9 deficiency exacerbates left ventricular dysfunction, increases infarct size, and augments cardiac fibrosis in mice with MI. In contrast, replenishment of BMP9 significantly attenuates these adverse effects. We further demonstrate that BMP9 improves lymphatic drainage function, thereby leading to a decrease of cardiac edema. In addition, BMP9 increases the expression of mitochondrial DECR1 (2,4-dienoyl-CoA [coenzyme A] reductase 1), a rate-limiting enzyme involved in β-oxidation, which, in turn, promotes cardiac mitochondrial bioenergetics and mitigates MI-induced cardiomyocyte injury. Moreover, DECR1 deficiency exacerbates MI-induced cardiac damage in mice, whereas this adverse effect is restored by the treatment of adeno-associated virus-mediated DECR1. Consistently, DECR1 deletion abrogates the beneficial effect of BMP9 against MI-induced cardiomyopathy and cardiac damage in mice. CONCLUSIONS: These results suggest that BMP9 protects against MI by fine-tuning the multiorgan cross-talk among the liver, lymph, and the heart.
引用
- Duan, Huang, Lei, et al. Bone Morphogenetic Protein 9 Protects Against Myocardial Infarction by Improving Lymphatic Drainage Function and Triggering DECR1-Mediated Mitochondrial Bioenergetics. Circulation. 2024. PMID: 39315433. doi:10.1161/CIRCULATIONAHA.123.065935
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。